Cardio Diagnostics Holdings (CDIO) Current Assets (2021 - 2026)
Cardio Diagnostics Holdings (CDIO) posted Current Assets of $7.7 million for Q1 2026, up 30.81% sequentially from $5.9 million in Q4 2025, and down 26.49% YoY from $10.5 million in Q1 2025.
Cardio Diagnostics Holdings (CDIO) Current Assets (2021 - 2026) Analysis & Trends
Cardio Diagnostics Holdings has reported Current Assets for 6 years, with the latest figure at $7.7 million in Q1 2026.
- Quarterly Current Assets fell 26.49% year-over-year to $7.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.7 million (down 26.49% YoY) and the FY2025 annual result came in at $5.9 million, down 32.65% from the prior year.
- Current Assets advanced to $7.7 million in Q1 2026 per CDIO's latest filing, from $5.9 million in the prior quarter.
- Over five years, Current Assets peaked at $10.5 million in Q1 2025 and troughed at $186119.0 in Q2 2022.
- A 5-year average of $5.0 million and a median of $5.9 million in 2022 frame the typical range for Current Assets.
- The sharpest annual moves came in 2023 and 2024: Current Assets jumped 3260.6% in 2023, then slumped 68.18% in 2024.
- Over 5 years, Current Assets stood at $5.9 million in 2022, then tumbled by 53.01% to $2.8 million in 2023, then jumped by 217.85% to $8.8 million in 2024, then plunged by 32.65% to $5.9 million in 2025, then soared by 30.81% to $7.7 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $7.7 million, $5.9 million, and $6.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | 1.76 Bn |
| 10 | Cardio Diagnostics Holdings | 6.14 Mn | 554,201.32 | - | 6.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.16 Mn |
| Mar 31, 2026 | 7.74 Mn |
| Dec 31, 2025 | 5.92 Mn |
| Sep 30, 2025 | 6.93 Mn |
| Jun 30, 2025 | 8.70 Mn |
| Mar 31, 2025 | 10.54 Mn |
| Dec 31, 2024 | 8.79 Mn |
| Sep 30, 2024 | 2.63 Mn |
| Jun 30, 2024 | 2.14 Mn |
| Mar 31, 2024 | 2.59 Mn |
| Dec 31, 2023 | 2.77 Mn |
| Sep 30, 2023 | 4.52 Mn |
| Jun 30, 2023 | 6.25 Mn |
| Mar 31, 2023 | 8.14 Mn |
| Dec 31, 2022 | 5.89 Mn |
| Sep 30, 2022 | 228,052.00 |
| Jun 30, 2022 | 186,119.00 |
| Mar 31, 2022 | 635,710.00 |
| Dec 31, 2021 | 803,507.00 |